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A Trifunctional Linker for Palmitoylation and Peptide and
Protein Localization in Biological Membranes
Łukasz Syga,[b] Reinder H. de Vries,[a] Hugo van Oosterhout,[a] Rianne Bartelds,[b]
Arnold J. Boersma,[c] Gerard Roelfes,*[a] and Bert Poolman*[b]
Introduction
The traffic of proteins to the proper localization in the cell is
necessary for their function. In many instances signal sequen-
ces determine the destination of a protein, be it the insertion
within a membrane or translocation into the lumen of a com-
partment of a cell.[1–3] Remarkably, changes of a single amino
acid residue can change the localization of lipoproteins from
the inner to the outer membrane of Escherichia coli and vice
versa.[4] Furthermore, reaching the correct compartment or
target membrane is not necessarily enough for proper func-
tioning of the protein. Biological membranes are heterogene-
ous in structure and localization within a specific membrane
domain has been shown to affect the function of for example,
Lymphocyte function-associated antigen 1 and Toll-like recep-
tor 2, which are moved to more ordered domains upon bind-
ing of a substrate.[5–9] The signal output of K-Ras changes
when a lysine residue is changed into glutamine.[10] This modi-
fication altered the interaction of K-Ras with anionic lipids and
consequently the sorting of those lipids into nanodomains.[10]
Protein palmitoylation is a reversible post-translational modi-
fication whereby one or more palmitic acid group(s) are at-
tached to a cysteine residue (or more seldom, a serine or
threonine residue), and this modification has been implicated
in the localization of proteins within a given membrane.[11–14]
The palmitic acid group changes the hydrophobicity of the
complex and may drive its partitioning into a specific mem-
brane domain.[14] For example, the linker for activation of
T cells (LAT) is enriched in the raft phase of cell-derived vesicles
when palmitoylated.[15] In cells, the doubly palmitoylated H-Ras
protein is localized in a different compartment than the unpal-
mitoylated K-RAS.[16] In yeast, several amino acid permeases
(AAPs) have a C-terminal, amphipathic a-helix that associates
with the inner leaflet of the plasma membrane. In a subset of
these proteins, for example the amino acid transporters Gap1
and Tat2, this C-terminal helix is palmitoylated by a palmitoyl-
acyl transferase.[17] The deletion of the amphipathic a-helix
does not affect the apparent localization of Gap1 and Tat2 but
leads to diminished growth on non-fermentable carbon sour-
ces.[18] Overall, palmitoylation of membrane proteins is relative-
ly widespread in biology, but the functional significance of this
modification is in most cases far from clear.
Hydrophobic mismatch is also known as sorting principle for
membrane proteins. When the hydrophobic part of a mem-
brane protein or peptide and the lipid membrane have differ-
ent thickness, the lipids surrounding the protein are distorted
which comes with an energetic penalty.[19,20] Proteins preferen-
tially reside in lipid domains with matching thickness, which
Attachment of lipophilic groups is an important post-transla-
tional modification of proteins, which involves the coupling of
one or more anchors such as fatty acids, isoprenoids, phospho-
lipids, or glycosylphosphatidyl inositols. To study its impact on
the membrane partitioning of hydrophobic peptides or pro-
teins, we designed a tyrosine-based trifunctional linker. The
linker allows the facile incorporation of two different function-
alities at a cysteine residue in a single step. We determined the
effect of the lipid modification on the membrane partitioning
of the synthetic a-helical model peptide WALP with or without
here and in all cases below; palmitoyl groups in giant unilamel-
lar vesicles that contain a liquid-ordered (Lo) and liquid-disor-
dered (Ld) phase. Introduction of two palmitoyl groups did not
alter the localization of the membrane peptides, nor did the
membrane thickness or lipid composition. In all cases, the pep-
tide was retained in the Ld phase. These data demonstrate that
the Lo domain in model membranes is highly unfavorable for a
single membrane-spanning peptide.
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leads to segregation of proteins with different hydrophobic
thickness.[21–24]
WALP peptides are classical transmembrane peptide models
commonly used to study membrane protein/peptide behavior
in vitro[25–30] and in silico.[31–33] Their sequences consist of ala-
nine and leucine repeats flanked by tryptophan residues.
Series of WALP peptides with different length and sequences
have been developed.[34] Here, we use WALP derivatives to in-
vestigate the effect of palmitoylation on the localization of a
hydrophobic model peptide within the lipid domains of syn-
thetic membranes.
To study the effect of protein palmitoylation and hydro-
phobic matching, we designed a trifunctional linker to couple
a peptide or protein to both a fluorophore and (a) palmitoyl
chain(s). Trifunctional linkers and scaffolds are ubiquitous in
chemistry and serve a great variety of purposes. Even the sim-
plest linkers bearing three identical reactive groups can be
used, taking advantage of stochastic coupling or clever (sub-
stoichiometric) introduction of the test molecules.[35–37] Trifunc-
tional linkers bearing three different reactive groups are more
challenging to synthesize.[38–42] A very elegant option is a mole-
cule based on a tri-orthogonal “click” scaffold, combining in-
verse electron demand Diels–Alder (iEDDA) between a cyclooc-
tyne and a tetrazine moiety with a copper-catalyzed alkyne–
azide click (CuAAC) reaction as well as maleimide coupling.[43]
The combination of two CuAAC click reactions with an alde-
hyde and/or activated ester coupling is an alternative
option.[44] Herein we report the synthesis of a tyrosine-based
trifunctional linker in which the palmitoyl chains, fluorophore
and peptide are conjugated onto one scaffold via amide,
CuAAC and maleimide coupling, respectively. As membrane
model system to test the partitioning of hydrophobic peptides
we used phase-separating giant unilamellar vesicles (GUVs).
The chosen lipid compositions separate the GUV membrane
into liquid-ordered (Lo) and liquid-disordered (Ld) phases.
[45,46]
In addition, we studied the effect of palmitoylation and hydro-
phobic mismatch in this system. We find that the lipid modifi-
cation of the hydrophobic peptide does not affect its mem-
brane partitioning and that the Lo phase is disfavored for all
molecules and lipid compositions tested.
Results
Synthesis of tyrosine-based trifunctional linker and charac-
terization of palmitoylated and fluorophore-coupled
peptides
Amino acids are a good starting point for the development of
a trifunctional linker, as most naturally occurring amino acids
already contain three functional groups. For the trifunctional
linker designed here, a maleimide was introduced on O-prop-
argyltyrosine, followed by an amide coupling with phospho-
lipid 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE)
to mimic two palmitoyl moieties. The propargyl allows CuAAC
with a fluorescent dye (Sulfo-Cy3 azide), while the maleimide
undergoes a Michael reaction with an introduced cysteine in
the WALP23 peptide (sequence: GCGWW(LA)8LWWA;
Scheme 1).
Scheme 1. Trifunctional linker used to conjugate 1) DPPE via amide coupling, 2) Sulfo-Cy3 azide via CuAAC, and 3) WALP via maleimide coupling.
Scheme 2. Synthetic route toward scaffold 5.
ChemBioChem 2020, 21, 1 – 10 www.chembiochem.org  2020 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim2&
 These are not the final page numbers!
Full Papers
We developed a synthetic route starting from Boc-tyrosine
methyl ester (Scheme 2). First, a propargyl moiety was installed
on the phenolic-OH after which 1 was obtained in high yields
(Supporting Information). Boc-deprotection followed by amide
coupling with 6-maleimidohexanoic acid, using DIC as a cou-
pling reagent, resulted in amide 3 in moderate yields. Using
the Nicolaou ester hydrolysis reaction,[47] employing trimethyl
tin hydroxide, the free acid (4) was obtained in high yields. In
the next step, DPPE was introduced on the carboxylic acid in a
two-step procedure. First, an activated ester of 4 was generat-
ed in situ, followed by rapid removal of the insoluble urea side
products. The activated ester was added to the solution con-
taining DPPE, resulting in the phospholipid-modified scaffold 5
in good yield.
The functionalization of the DPPE-modified linker 5 with
Sulfo-Cy3 azide via CuAAC gave the palmitoyl-dye (PD) prod-
uct 7 in 24% yield after preparative HPLC purification
(Scheme 3). For control experiments, free acid 4 (without
DPPE) was also labeled with Sulfo-Cy3 using the same proto-
col, after which control conjugate 6 was obtained in 47%
yield. Subsequent conjugation of 6 and 7 with WALP followed
by preparative HPLC purification afforded the WALP-dye (WD,
8) and WALP-palmitoyl dye (WPD, 9) constructs, respectively
(Scheme 3).
Partitioning of the tyrosine-based trifunctional linkers and
WALP in phase-separating GUVs
We determined the localization and partitioning of the WALP
peptide with and without palmitoyl moiety in phase-separat-
ing GUVs composed of DPPC, DOPC, and cholesterol in 4:3:3
molar ratio (Figure 1A). This lipid composition results in mem-
branes with distinct phases, with most of the DPPC and choles-
Scheme 3. Sequential conjugation of Sulfo-Cy3 and WALP on scaffolds 4 and 5.
Figure 1. Partitioning of the constructs within the membrane domains of
phase-separating GUVs. A) 3D reconstructions of GUVs with the SulfoCy3-la-
beled constructs in green and the Ld marker in red (Atto655). B) Pearson cor-
relation for the construct relative to the marker (left), and the ratio of the
molecules for Lo and Ld (Lo/Ld ratio; right). Error bars represent the standard
deviation of three separate preparations of the GUVs.
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terol in the so-called Lo phase and most of the DOPC in the Ld
phase.[48] The constructs WALP-palmitoyl-dye (WPD; construct
9), WALP-dye (WD; construct 8), and palmitoyl-dye (PD; con-
struct 7) were used. Each construct was imaged with Atto655-
DOPE as marker of the Ld phase. The Atto 655 dye displays
minimal interaction with the membrane.[49] The Pearson corre-
lation coefficient for the constructs (7, 8 or 9) relative to the Ld
marker was calculated to signify the preference of the modi-
fied peptide in either of the phases. A Pearson’s correlation co-
efficient of 1 indicates that the two signals increase and de-
crease identically, whereas a value of 0 indicates a random rela-
tion between the signals. A negative value would indicate anti-
correlation of two signals. We also determined the ratio of the
molecules for the two phases (Lo/Ld), using the mean fluores-
cence in each phase as a measure of the partition coefficient
of the constructs. The palmitoyl lipid (PD) has a slight prefer-
ence for Ld (Lo/Ld ratio of 0.710.21), whereas the constructs
with WALP (WPD and WD) partition almost exclusively in Ld
(Figure 1B). To eliminate the possibility that the localization of
WPD and WD in Ld is biased by aggregation of the peptide, ex-
periments at 100-fold lower concentration of the functional-
ized peptides were performed. The results were the same, and
clearly, the palmitoyl moiety is not sufficient to transfer the
WALP peptide from the Ld to the Lo phase (Figure S1 in the
Supporting Information).
Lipid acyl chain saturation, not acyl chain length,
determines localization of WALP
Next, we investigated the effect of membrane thickness on the
partitioning of the constructs. To this end, we varied the
length of the acyl chains of the lipids, yet maintaining distinct
Ld and Lo phases. We prepared GUVs composed of cholesterol
plus DPPC (16:0)/DOPC (18:1), and GUVs made from cholester-
ol plus PC with different acyl chain composition: 16:0/16:1,
18:0/18:1, and 18:0/16:1. For these mixtures we assume that
the majority of DPPC (16:0) and DSPC (18:0) is in Lo and the
majority of DOPC and 16:1 PC in Ld.
[50] Additionally, mixtures
with 14:0, 14:1, and 22:0 PC lipids were tested but conditions
resulting in phase-separation were not found. All the con-
structs co-localize with the Ld marker used, which in all cases
indicates a preference for the unsaturated lipid, independent
of its acyl chain length (Figure 2).
The localization of a molecule in the Ld or Lo phase of a
membrane affects its lateral diffusion. Because the mobility of
molecules in the Ld phase is much faster than in the Lo
phase,
[45] we determined the lateral diffusion coefficient of
Atto655-DOPE in GUVs prepared from different lipid composi-
tions. The diffusion coefficients (D) were: 1.530.41 (n=12),
3.110.55 (n=8), 1.100.256 (n=10), and 1.040.154 (n=5)
mm2s1 (SD) for the 16:0/18:1, 16:0/16:1, 18:0/18:1, and
18:0/16:1 mixtures, respectively. These values are consistent
with lipid diffusion in the Ld phase and at least an order of
magnitude faster than what is expected for Lo.
[45,51] Thus, we
conclude that in all these lipid mixtures the Atto655-DOPE lo-
calizes in the Ld phase of GUVs.
The length of WALP does not affect the membrane
localization
Next, we increased the length of the WALP peptide to better
fit the hydrophobic thickness of the Lo phase, which is 0.7 to
1 nm larger than in the Ld phase.
[52–54] WALP27 is four amino
acids longer than the WALP-23, which results in an increase in
the length of the hydrophobic part of 0.6 nm.[55] We also deter-
mined the partitioning of WALP27 in the presence of up to
5 mol% of GM1, which induces tighter lipid packing and is
thought to be a major component of rafts in mammalian
cells.[56] GM1 is relatively abundant in plasma membranes of
the central nervous system of mammals.[57] WALP27 labelled
with AlexaFluor 488 (Supporting Information) co-localized with
the Ld marker DiD in the phase-separating GUVs, irrespective
of the presence of GM1 (Figure 3).
Figure 2. Effect of lipid composition of the GUVs on the localization of
WALP constructs with or without a palmitoyl group. The Pearson correlation
for the construct relative to the marker (left), and the ratio of the molecules
for Lo and Ld (Lo/Ld ratio; right) are shown. Error bars represent the standard
deviation of three separate preparations of the GUVs.
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Discussion
We report the synthesis and use of a trifunctional linker to
study the localization of membrane proteins and peptides in
phase-separating giant unilamellar vesicles (GUVs). The linker
allows great flexibility in connecting a triage of molecules such
as fluorophores, peptides (or proteins) and other functionali-
ties, such as lipid moieties. It is possible to selectively modify
peptides (or proteins) with two different functional groups in a
single step. Our synthetic approach of coupling two palmitoyl
groups of DPPE to a membrane peptide via the trifunctional
linker differs from biological systems where the lipid moieties
are attached to cysteine on the peptide.
WALP and derivative peptides are commonly used as a-heli-
cal models of membrane proteins and their interaction with
lipid membranes has been studied extensively.[58–60] The mem-
brane localization and structure of WALP have been studied in
silico and in vitro, using phase-separating GUVs. With both
approaches, WALP localizes in the Ld phase of the mem-
branes.[26,28, 61,62] Consistent with these findings, WALP is found
in the detergent-soluble fraction of phase-separating large uni-
lamellar vesicles,[63] which is analogous to the Ld phase of GUVs
observed by optical microscopy.[64–67] We show that the parti-
tioning of the WALP with trifunctional linker is identical to that
of genuine membrane peptides. Additionally, WALP partitions
in the Ld phase even when two Lo-favoring palmitoyl groups
are added via the trifunctional linker. The construct without
WALP (PD) is distributed almost equally between Lo and Ld do-
mains. This result was expected as even GM1, one of the defin-
ing components of rafts,[5] needs to be complexed with cholera
toxin to stain the Lo phase specifically.
[68] Adding two palmitoyl
tails to the WALP peptide lowers the energy barrier for entry
into Lo phase, but not enough for WALP to localize into the
more ordered parts of GUVs with our tertiary lipid composi-
tions. Hydrophobic mismatch created by changing the lipid
composition of the membrane or the hydrophobic length of
the WALP peptide does not alter the localization or partition-
ing significantly, irrespective of the presence of palmitoyl
groups.
Palmitoylation has been shown to affect the membrane lo-
calization of LAT and hemagglutinin.[69] LAT is localized in the
Lo phase of giant plasma membrane vesicles, and the partition-
ing in Lo is diminished after depalmitoylation.
[15] However, LAT
does not localize in the Lo of GUVs composed of DSPC (18:0;
33.3 mol%), DOPC (18:1; 31.7 mol%), DOPG (18:1; 1.6 mol%)
plus cholesterol (33.3 mol%). In addition, palmitoylation of LAT
does not affect the partitioning of the molecule in these vesi-
cles,[70] which is consistent with our findings on the localization
of WALP with or without palmitoyl groups.
What could be the reason for the apparent inconsistency in
the membrane domain partitioning of LAT and other mem-
brane proteins or peptides? The liquid-ordered and liquid-dis-
ordered domains of membranes are qualitative descriptions of
lipid ordering, and, depending on the actual lipid composition,
a domain can be more, or less, ordered or disordered. We have
attempted to address this point by varying the lipid composi-
tion of the membrane, while conserving microscopically ob-
servable Lo and Ld phases. We have lowered the energy barrier
for entering the Lo domain by creating hydrophobic mismatch,
but we always find WALP associated with Ld. We cannot rule
out that the transfer from Ld to Lo is more favorable in giant
plasma membrane-derived vesicles, consisting of hundreds of
different lipid components,[69] that phase separate with a small-
er difference in lipid order between Lo and Ld.
[46] We also note
that the angle at which WALP crosses the membrane does not
vary much with the membrane thickness.[27,71] In fact, in thin
membranes with very high hydrophobic mismatch the pep-
tides are no longer incorporated in the membrane rather than
highly tilted.[71] Finally, in vivo, factors such as accessible sur-
face area can also affect the partitioning of membrane pep-
tides and proteins;[72] we have not investigated this aspect.
GM1, a ganglioside, is often used as raft marker[73–75] and as-
sociated with the Lo phase.
[76–78] GM1 has been shown to inter-
act with WALP and LAT, thereby favoring the partitioning of
the peptides in the Lo phase, at least in coarse grained molecu-
lar dynamics simulations.[61] All-atom simulations contradict
these findings and show depletion of GM1 near WALP.[79] We
note that the latter experiments were carried out in uniform
phospholipid bilayers rather than phase-separating mem-
branes. GM1 could form small nanodomains inside the Lo
phase,[77,80,81] thereby preventing interaction with WALP. Clus-
ters of GM1 have been found in cell membranes,[80] but also in
supported bilayers.[76,77,81] In any case, direct interaction of GM1
and WALP in phase-separating membranes seems unlikely, at
least in our experimental system, because they are spaciously
Figure 3. Confocal images of giant-unilamellar vesicles (GUVs). Hydrophobic
mismatch and GM1 do not alter the localization of WALP peptides as
WALP27 (like WALP23) partitions preferentially in the Ld phase. WALP27 was
labeled directly with AF-488 (Supporting Information); DiD was used as Ld
marker.
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separated with GM1 in the Lo phase and WALP in the Ld
phase.[62,63]
Conclusion
We present the design and synthesis of a new tyrosine-based
trifunctional linker, which enables conjugation of precious pro-
tein with two functional molecules in one step. To show the
potential of our modular platform we study localization and
partitioning of membrane-embedded peptides. Contrary to
our initial hypothesis, we find in GUVs, prepared from a variety
of lipid mixtures, that a double palmitoyl moiety is not suffi-
cient to change the partitioning of a single-membrane spanner
like WALP.
Experimental Section
Materials: Lipids were obtained from Avanti Polar Lipids, Inc: 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC; product number
850375), 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (product
number 850358), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC; product number 850355), 1,2-distearoyl-sn-glycero-3-phos-
phocholine (DSPC, product number 850365).
For immobilization of GUVs, we used glutaraldehyde from Sigma–
Aldrich, product number 340855. APTES ((3-Aminopropyl) trieth-
oxysilane) was obtained from Sigma–Aldrich, product number
440140. WALP (GCGWW(LA)8LWWA) was purchased from Bachem.
Sulfo-Cyanine3 azide (Sulfo-Cy3) was purchased from Lumiprobe.
All other chemicals were reagent grade and obtained from various
commercial sources. High precision coverslips (type #1.5H) were
obtained from Ibidi GmbH (product no. 10812). Reactions were
monitored by TLC Silica 60 (Merck Millipore), examined under UV
(365 nm and 254 nm), and stained by KMnO4, ninhydrin, vanillin or
H2SO4 in MeOH (1%). Flash chromatography was performed on
Silica gel 60 (0.040–0.063 mm) from Merck Millipore. 1H NMR spec-
tra were recorded at 300 or 400 MHz and 13C NMR spectra were re-
corded at 75 MHz. The chemical shifts are reported in ppm relative
to the residual solvent peak (CDCl3 at dH=7.26 ppm, dC=
77.16 ppm). Yields of the dye constructs were based on UV absorp-
tion at 548 nm and the molar absorptivity coefficient of Sulfo-Cy3
azide (e=162000m1 cm1 at 548 nm), not compensating for the
presence of lipid or linker (assumed to not absorb in that region).
HPLC was performed on a Shimadzu HPLC system equipped with
LC-20AD solvent chromatographs, a DGU-20A3 degasser unit, a
SPD-M20A PDA detector, a SIL-20A autosampler, a CTO-20A
column oven, a CBM-20A system controller and a FRC-10A fraction
collector. LC–MS analysis was performed on a Waters Acquity UPLC
with TQD mass detector (ESI). High-resolution mass spectra (ESI)





3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid 4 (100 mg,
0.25 mmol, 3.5 equiv) was dissolved in freshly distilled THF (3 mL)
in a 10 mL Schlenk flask under an argon atmosphere. N-Hydroxy-
succinimide (40 mg, 0.35 mmol, 4.8 equiv) and dicyclohexylcarbo-
diimide (65 mg, 0.3 mmol, 4.1 equiv) were added, and the mixture
was stirred for 2 h until the starting material was fully consumed
on TLC. The mixture was then filtered over Celite to remove the
white precipitate and concentrated to about 1 mL in volume.
While stirring the first solution, a second mixture of DPPE (50 mg,
0.07 mmol, 1 equiv) in chloroform (4 mL) was made using a few
drops of 2,6-lutidine to aid the dissolving process (repeated heat-
ing/sonication cycles were required). After cooling down the DPPE-
solution to room temperature, it was placed in a sonicating bath
before the concentrated solution containing the O-succinimide
was added dropwise, making sure the solution did not precipitate.
After addition, the clear solution was left to stir for 20 h. The mix-
ture was then diluted to 10 mL using additional chloroform and
washed with 0.1m HCl (aq.) (10 mL), water (10 mL) and brine
(10 mL). The organic layer was then dried over Na2SO4, filtered and
dried in vacuo, to obtain the crude product as a yellow oil. Flash
chromatography (silica, MeOH/CH3Cl/NH3 5:95:0.1 to 20:80:0.1 in
three steps) afforded the product as a clear oil that later turned
into a glassy film (43 mg, 0.04 mmol, 57%). 1H NMR (400 MHz,
CDCl3): d=7.13 (d, J=8.1 Hz, 2H), 6.84 (d, J=8.2 Hz, 2H), 6.69 (s,
2H), 5.16 (m, 1H), 4.82 (m, 1H), 4.64 (d, J=2.4 Hz, 2H), 4.33 (d, J=
11.6 Hz, 1H), 3.94 (m, 7H), 3.39 (t, J=7.3 Hz, 2H), 3.06 (m, 1H), 2.83
(m, 1H), 2.54 (t, J=2.4 Hz, 1H), 2.23 (t, J=7.7 Hz, 4H), 2.05 (m, 2H),
1.53 (m, 4H), 1.39 (m, 4H), 1.24 (m, 48H), 1.06 (m, 2H), 0.86 ppm
(m, 6H); HRMS (ESI): m/z calcd for C59H95N3O13P: 1084.661
[MH] , found 1084.662.
General procedure for labeling with Sulfo-Cy3 (Example tyro-
sine-based linker without DPPE (4)) (6): Maleimidohexyl modified
O-propargyloxy-l-tyrosine carboxylic acid 4 (0.42 mg, 1 mmol,
1 equiv) and Na-ascorbate (0.6 mg, 3 mmol, 3 equiv) were added to
a stained (brown) HPLC vial (1.5 mL) equipped with a screw-cap
and solubilized using 50 mL TFE. Sulfo-Cy3 Azide (0.83 mg,
1.33 mmol, 1.33 equiv) in 50 mL tBuOH/ddH2O 5:1 was then added.
A mixture of CuSO4 (1.2 mg, 7.5 mmol) and THPTA (5.3 mg,
12.2 mmol) in 2.79 mL ddH2O was prepared simultaneously and
46 mL of this solution was added to the reaction vial. The mixture
was stirred at RT in the dark overnight, then filtered using a
0.45 mm microfilter and purified using semi-preparative HPLC
(Waters Cortecs HILIC 2.7 mm 4.6150 mm column, solvent A:
0.1% FA in ACN, solvent B: 0.1% FA in ddH2O, gradient: 5% B to
45% B over 30 min, flow: 0.5 mLmin1). Analytical HPLC (same con-
ditions): tR=22 min (broad). The pure fractions were pooled and
lyophilized and the product (6) was obtained as a purple solid
(0.5 mg, 0.47 mmol, 47%). HRMS (ESI) m/z calcd for C55H65N8O13S2
 :
1109.412 [M2H] , found 1109.411.
Synthesis of tyrosine-based linker with DPPE labelled with
Sulfo-Cy3 (7): Maleimidohexyl (dipalmitoylglyceryl-phosphatidyl)-
ethanolamide modified O-propargyloxytyrosine 5 (1.1 mg, 1 mmol,
1 equiv) was treated according to the above general procedure.
The mixture was filtered using a 0.45 mm microfilter and purified
using semi-preparative HPLC (XBridge C18 5 mm 4.6150 mm
column, solvent A: 0.1% NH3 in ACN, solvent B: 0.1% NH3 in
ddH2O, gradient: 60% B to 5% B over 40 min, flow: 0.5 mLmin
1).
The obtained fractions were analyzed using LC–MS (ESI , Waters
BEH C18 1.7 mm 2.150 mm column, solvent A: 0.1% NH3 in
ddH2O, solvent B: 0.1% NH3 in ACN, gradient: 90% A to 50% A
over 8 min, to 5% A in 1 min, total runtime: 15 min) tR=11.28 min,
m/z=1782.9 [M2H] . The pure fractions were pooled and lyophi-
lized and the product (7) was obtained as a purple solid (0.43 mg,
0.24 mmol, 24%). HRMS (ESI) m/z calcd for C92H136N9O20PS2
2 :
890.955 [M3H]2, found 890.953.
Synthesis of WALP-Sulfo-Cy3 hybrid using Sulfo-Cy3 labelled ty-
rosine-based linker without DPPE (8): WALP (1.5 mg, 0.48 mmol;
80% purity) was placed in a Schlenck tube, which was brought
under argon atmosphere; 250 mL of a 0.94 mm solution of Sulfo-
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Cy3 labeled tyrosine-based linker without DPPE (6) in TFE
(0.24 mmol) was added, followed by 0.84 mL DIPEA and the mixture
was stirred in the dark at RT overnight. 100 mL ddH2O/ACN 1:1 was
added, and the mixture was filtered using a 0.45 mm microfilter.
The clear filtrate was purified using semi-preparative HPLC
(XBridge C18 5 mm 4.6150 mm column, solvent A: 0.1% NH3 in
ACN, solvent B: 0.1% NH3 in ddH2O, gradient: 60% B to 5% B over
40 min, flow: 0.5 mLmin1). The obtained fractions were analyzed
using LC–MS (ESI , Waters BEH C18 1.7 mm 2.150 mm column, sol-
vent A: 0.1% NH3 in ddH2O, solvent B: 0.1% NH3 in ACN, gradient:
90% A to 50% A over 8 min, to 5% A in 1 min, total run time:
15 min); tR=7.55 min, m/z=1248.0 [M4H]3 ; HRMS (ESI) m/z
calcd for C187H261N37O39S3
2 : 1872.438 [M3H]2, found 1872.440;
m/z calcd for C187H260N37O39S3
3 : 1247.956 [M4H]3, found
1247.960; m/z calcd for C187H259N37O39S3
4 : 935.715 [M5H]4,
found 935.718.
Synthesis of WALP-Sulfo-Cy3 hybrid using Sulfo-Cy3 labelled ty-
rosine-based linker with DPPE (9): WALP (0.8 mg, 0.24 mmol;
80% purity) was placed in a Schlenck tube, which was brought
under Ar atmosphere; 250 mL of a 0.48 mm solution of Sulfo-Cy3
labeled tyrosine-based linker with DPPE (7) in TFE (0.12 mmol) was
added, followed by 0.42 mL DIPEA and the mixture was stirred in
the dark at room temperature overnight. 100 mL ddH2O/ACN 1:1
was added and the mixture was filtered using a 0.45 mm microfilter.
The clear filtrate was purified using semi-preparative HPLC
(XBridge C8 5 mm 4.6150 mm column, solvent A: 0.1% NH3 in
ACN, solvent B: 0.1% NH3 in ddH2O, gradient: 60% B to 5% B over
40 min, flow: 0.5 mLmin1). The obtained fractions were analyzed
using LC–MS (ESI , Waters Protein BEH C4 1.7 mm 2.1150 mm
column, solvent A: 0.1% NH3 in ddH2O, solvent B: 0.1% NH3 in
ACN, gradient: 70 to 30% A over 8 min, to 5% A in 1 min, total
run time: 20 min), tR=10.82 min, m/z=1472.7 [M4H]3 ; HRMS
(ESI): m/z calcd for C224H332N38O46PS3
3 : 1472.458 [M4H]3, found
1472.457; m/z calcd for C224H331N38O46PS3
4 : 1104.091 [M5H]4,
found 1104.090.
GUV formation: GUVs composed of saturated lipids (DPPC, DSPC),
double mono-unsaturated lipids (DOPC, 16:1 PC), and cholesterol
in a 4:3:3 molar ratio were formed by electroformation.[45] For im-
mobilization purposes 0.1 mol% of DOPE was added to each of
the mixtures, as described previously.[51] The labelled WALP peptide
together with the Ld phase markers ATTO 655 DOPE, or DiD, were
added to the lipid mixture in a 1:1000 molar ratio, unless stated
otherwise. Atto 655 is a water-soluble, zwitterionic fluorophore
coupled to a lipid that is excited in the far red and spectrally dis-
tinct from Sulfo-Cy3. Around 400 nmol of lipids, together with Ld
marker and WALP were spotted on a conductive indium tin oxide
(ITO)-coated glass plate. After removal of the solvents under
vacuum, GUVs were formed in 200 mm sucrose on the Vesicle Prep
Pro (Nanion technologies) with a voltage of 1.1 V at 10 Hz for 1 h
at 50 8C.
Immobilization of GUVs: GUVs were immobilized on slides modi-
fied with APTES-glutaraldehyde as described previously.[51] In short,
coverslips were cleaned in KOH and plasma cleaned. They were
then modified in 2% APTES solution for 10 seconds and stored in
vacuum until the day of the experiment but always within 48 h.
Prior to the experiment, slides were incubated with 5% glutaralde-
hyde for 30 min, after which the glutaraldehyde was washed away
with ddH2O. Subsequently, the GUVs, diluted 10 times in 100 mm
NaCl, were placed on the slide.
Imaging: GUVs were imaged on the Zeiss LSM 710 confocal micro-
scope with a 40x C-Apochromat Corr M27 with NA 1.2 water im-
mersion objective. ATTO 655 DOPE and DiD were excited with a
633 nm HeNe laser; the Sulfo-Cy3 coupled to the WALP peptide
was excited with a 543 nm HeNe laser. Z-stack images of immobi-
lized GUVs were taken. The images of both channels were taken
separately to avoid cross talk.
Image analysis: The GUVs were automatically identified by detect-
ing circles in the image. The detection of circles was done using a
circle Hough transform[82] for a range of radii, resulting in a stack of
images; one image for each radius. We then created a maximum
intensity projection where each pixel contains the maximum value
over all images in the stack at the particular pixel location. On this
projection we detect peaks by repeatedly finding the brightest
pixel, which gives us the centers of the detected GUVs. The radius
of each GUV corresponds to the radius on which the maximum
pixel value was found when we created the maximum intensity
projection (Figure S2).
After detection of the circles on the image, the non-phase-separat-
ing GUVs were filtered out. We calculated the Pearson’s correlation
coefficient for the fluorescent profile of the Ld marker relative to
the same profile that was smoothened. Smoothening was done
with a moving average filter. A high correlation indicates two sepa-
rate phases, while low correlation is consistent with a single-phase
vesicle. We used the correlation of 0.9 as a cut off for phase-sepa-
rating vesicles. After the automatic detection all selections were
manually inspected and false positives were removed. We used the
smoothened profile of the Ld marker to classify each intensity
value as being either in the Ld or Lo phase based. Next, the correla-
tion between the Ld marker and target construct, and the ratio of
the mean intensity of the fluorescence in the Lo and Ld phases,
were calculated on the non-smoothened profiles (an overview of
the data analysis is presented in Figure S3).
FRAP experiments: FRAP measurements were performed by imag-
ing a small area of the membrane of the GUVs to achieve an ac-
quisition time below 40 ms. A spot with a diameter of 1 mm was
bleached at high laser intensity, after which the attenuated laser
was used to record images every 40 ms for 6 s; the pre-bleaching
fluorescence was obtained from five images prior to the bleach.
The halftime of recovery and lateral diffusion coefficients were
calculated as described previously,[83] which is based on work of
Axelrod and colleagues.[84]
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A Trifunctional Linker for
Palmitoylation and Peptide and
Protein Localization in Biological
Membranes
Attachment of lipophilic groups is an
important post-translational modifica-
tion of proteins. To study its impact on
the membrane partitioning of hydro-
phobic peptides/proteins, we designed
a tyrosine-based trifunctional linker that
allows facile incorporation of two differ-
ent functionalities at a cysteine residue
in a single step. Shown is a liquid-disor-
dered phase of a giant unilamellar vesi-
cle (green semicircle), trifunctional linker
(blue) connected to a fluorophore
(black), DPPE lipid (brown), and protein.
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